Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;16(2):86-96.
doi: 10.5152/ttd.2015.4555. Epub 2015 Apr 1.

Updates in Chronic Obstructive Pulmonary Disease for the Year 2014

Sibel Atış Naycı  1 , Lütfi Çöplü  2 , Alev Gürgün  3 , Nurdan Köktürk  4 , Mehmet Polatlı  5 , Elif Şen  6 , Sema Umut  7 , Esra Uzaslan  8 , Nurhayat Yıldırım  7 , Peter J Barnes  9
Affiliations
Review

Updates in Chronic Obstructive Pulmonary Disease for the Year 2014

Sibel Atış Naycı et al. Turk Thorac J. 2015 Apr.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Turk Thorac J. 2015 Jul;16(3):140. Epub 2015 Jul 1. Turk Thorac J. 2015. PMID: 29404092 Free PMC article.

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality in the world. Research conducted over the past decade has contributed much to our current knowledge of the pathogenesis and treatment of COPD. Additionally, an evolving literature has recently accumulated information about the management of COPD and also about exacerbations. This article reviews a concise summary on the updates in COPD including 1) new pathogenic mechanisms and therapeutic targets, 2) management of patients in Group B, C and D according to GOLD 2014 report; 3) prevention and management of exacerbation; 4) monitoring of natural history; and 5) essential but usually forgotten parts of the management.

Keywords: COPD; disease management; exacerbation; natural history.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

Figures

Figure 1
Figure 1
Fletcher-Peto curve [46]
See this image and copyright information in PMC

References

    1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Immunol Rev. 2008;8:183–92. http://dx.doi.org/10.1038/nri2254. - DOI - PubMed
    1. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharm Rev. 2004;56:515–48. http://dx.doi.org/10.1124/pr.56.4.2. - DOI - PubMed
    1. Di Stefano A, Caramori G, Gnemmi I, et al. Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients. Clin Exp Immunol. 2009;157:316–24. http://dx.doi.org/10.1111/j.1365-2249.2009.03965.x. - DOI - PMC - PubMed
    1. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013;131:636–45. http://dx.doi.org/10.1016/j.jaci.2012.12.1564. - DOI - PubMed
    1. To Y, Ito K, Kizawa Y, et al. Targeting phosphoinositide-3-kinase-d with theophylline reverses corticosteroid insensitivity in COPD. Am J Resp Crit Care Med. 2010;182:897–904. http://dx.doi.org/10.1164/rccm.200906-0937OC. - DOI - PMC - PubMed

LinkOut - more resources